Sie Ventures
VC Fund
Sie Ventures is a VC fund focused on Biotechnology and E-Commerce. SIE
- Total investments:
- 13
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries Sie Ventures invests in
Stages Sie Ventures invests in
Countries Sie Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.1M–$9.5M
- Pre-Seed
- $1.5M–$2.8M
Investment Focus
Industry
- Biotechnology 4 (31%)
- E-Commerce 2 (15%)
- CRM 1 (8%)
- SaaS 1 (8%)
- Mobile 1 (8%)
Stage
- Seed 8 (62%)
- Pre-Seed 2 (15%)
- Venture - Series Unknown 2 (15%)
- Series B 1 (8%)
Country
- United Kingdom 10 (77%)
- Spain 1 (8%)
- France 1 (8%)
- Estonia 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Triin Linamagi
Founding Partner
|
Founding Partner | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Zonova has developed an antimicrobial additive technology that integrates directly into the polymers used in medical device manufacture, designed to help prevent healthcare-associated infections, a problem affecting roughly 1 in 10 hospital patients worldwide (WHO, 2011). Our patented Z-ROS® chemistry is a non-leaching antimicrobial additive basedon reactive-oxygen-species generation at the polymer surface. It does not use actives, antibiotics or biocides.Z-ROS® is in development for high infection-risk device categories including vascular access devices, orthopaedic implants, urology (connectors, valves, catheters), endotracheal tubes, and pelvic health devices. The intended commercial model is licensing to medical device manufacturers, with masterbatch supply through a contracted compounder. | $2.8M / Seed / May 26, 2026 | ||
| Biographica is a computational biology company that develops software tools and platforms to support genomic data analysis, interpretation, and visualization for research and clinical applications. Its solutions are designed to help scientists, clinicians, and bioinformaticians process complex genomic datasets, annotate genetic variants, andexplore biological insights through integrated workflows and interactive visualizations. The company’s platform combines data management, algorithmic analysis, and graphical interfaces to streamline tasks such as sequence alignment, variant calling, functional interpretation, and cohort comparison. Biographica’s tools support interoperability with common bioinformatics formats and pipelines, enabling users to integrate genomic workflows with existing research infrastructure. The company also provides APIs and developer tools to allow custom integration, automation, and extension of analytic capabilities within broader computational environments. Its offerings are used across life sciences research, translational projects, and precision medicine initiatives that require scalable, interpretable genomic data analysis. | $9.5M / Seed / Jan 07, 2026 | ||
| By Rotation is the world's first social fashion rental app. We're transforming the way fashion is consumed by allowing users to share their wardrobes. Do good for the planet, your wardrobe and your wallet at the same time. | Venture - Series Unknown / May 02, 2024 | ||
| Fifth Dimension AI is to analyze high-value data faster, create better content, and perform performing marketing. | $2.8M / Pre-Seed / Oct 11, 2023 | ||
| The first modular pico-labs for active in-space testing of advanced materials, from LEO to Cis-lunar and Interplanetary orbits. | $1.5M / Pre-Seed / Jul 21, 2023 | ||
| Grünfin is a sustainable investing platform for people who care about their impact. | $2.2M / Seed / Jan 17, 2023 | ||
| Emm is developing the next generation of consumer health tools to manage your health on your terms. We want to empower everyone to change the quality of their life by inherently understanding their health though technology and specialist knowledge. | $1.1M / Seed / Nov 28, 2022 | ||
| Rosaly gives you the ability to manage advance payment requests automatically and provide your staff with a financial management tool without having any negative effects on your cash flow.Rosaly is a fintech with real social effect that helps businesses improve the financial well-being of their employees by providing on-demand pay, budgetmanagement, and education through an app. Rosaly was started by Arbia Smiti at the end of 2019. | $7.5M / Seed / Sep 13, 2022 | ||
| Shareback creates AI personalization engines that build custom tools for individual team members. | Seed / Jun 30, 2022 | ||
| Your Juno is a financial education platform for women and non-binary people. | $2.2M / Seed / Mar 01, 2022 | ||
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sie Ventures invest in?
Sie Ventures invests primarily in Biotechnology, E-Commerce and CRM startups, most often at Seed and Pre-Seed stage. Most of the 13 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Sie Ventures invest in?
Sie Ventures typically joins rounds of $1.1M–$9.5M at Seed and $1.5M–$2.8M at Pre-Seed. These are whole funding-round sizes, not Sie Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Sie Ventures took part in.
How do I contact Sie Ventures?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Sie Ventures?
The team at Sie Ventures includes Triin Linamagi (Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
